222 related articles for article (PubMed ID: 20969773)
21. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.
Rheinwald JG; Hahn WC; Ramsey MR; Wu JY; Guo Z; Tsao H; De Luca M; Catricalà C; O'Toole KM
Mol Cell Biol; 2002 Jul; 22(14):5157-72. PubMed ID: 12077343
[TBL] [Abstract][Full Text] [Related]
22. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
Silva J; García JM; Peña C; García V; Domínguez G; Suárez D; Camacho FI; Espinosa R; Provencio M; España P; Bonilla F
Clin Cancer Res; 2006 Dec; 12(23):6929-36. PubMed ID: 17145810
[TBL] [Abstract][Full Text] [Related]
23. Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence.
Patel PL; Suram A; Mirani N; Bischof O; Herbig U
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5024-33. PubMed ID: 27503890
[TBL] [Abstract][Full Text] [Related]
24. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
25. Expression profiles of p53-, p16(INK4a)-, and telomere-regulating genes in replicative senescent primary human, mouse, and chicken fibroblast cells.
Kim H; You S; Farris J; Kong BW; Christman SA; Foster LK; Foster DN
Exp Cell Res; 2002 Jan; 272(2):199-208. PubMed ID: 11777345
[TBL] [Abstract][Full Text] [Related]
26. c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression.
Morrison CD; Allington TM; Thompson CL; Gilmore HL; Chang JC; Keri RA; Schiemann WP
Oncotarget; 2016 Nov; 7(45):72777-72794. PubMed ID: 27626309
[TBL] [Abstract][Full Text] [Related]
27. Low p16
Graham MK; Principessa L; Antony L; Meeker AK; Isaacs JT
Prostate; 2017 Mar; 77(4):374-384. PubMed ID: 27859428
[TBL] [Abstract][Full Text] [Related]
28. RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer.
Knudsen ES; McClendon AK; Franco J; Ertel A; Fortina P; Witkiewicz AK
Cell Cycle; 2015; 14(1):109-22. PubMed ID: 25602521
[TBL] [Abstract][Full Text] [Related]
29. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells.
Majumder B; Wahle KW; Moir S; Schofield A; Choe SN; Farquharson A; Grant I; Heys SD
FASEB J; 2002 Sep; 16(11):1447-9. PubMed ID: 12205043
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.
Ohashi S; Natsuizaka M; Wong GS; Michaylira CZ; Grugan KD; Stairs DB; Kalabis J; Vega ME; Kalman RA; Nakagawa M; Klein-Szanto AJ; Herlyn M; Diehl JA; Rustgi AK; Nakagawa H
Cancer Res; 2010 May; 70(10):4174-84. PubMed ID: 20424117
[TBL] [Abstract][Full Text] [Related]
31. Expression of proapoptotic BAX and TP53 genes and antiapoptotic BCL-2 gene in MCF-7 and T-47D tumour cell cultures of the mammary gland after a photodynamic therapy with photolon.
Płonka J; Latocha M; Kuśmierz D; Zielińska A
Adv Clin Exp Med; 2015; 24(1):37-46. PubMed ID: 25923085
[TBL] [Abstract][Full Text] [Related]
32. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
Morel AP; Hinkal GW; Thomas C; Fauvet F; Courtois-Cox S; Wierinckx A; Devouassoux-Shisheboran M; Treilleux I; Tissier A; Gras B; Pourchet J; Puisieux I; Browne GJ; Spicer DB; Lachuer J; Ansieau S; Puisieux A
PLoS Genet; 2012; 8(5):e1002723. PubMed ID: 22654675
[TBL] [Abstract][Full Text] [Related]
33. Generation of Immortalised But Unstable Cells after hTERT Introduction in Telomere-Compromised and p53-Deficient vHMECs.
Bernal A; Zafon E; Domínguez D; Bertran E; Tusell L
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018248
[TBL] [Abstract][Full Text] [Related]
34. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG.
Takahashi M; Seki N; Ozaki T; Kato M; Kuno T; Nakagawa T; Watanabe K; Miyazaki K; Ohira M; Hayashi S; Hosoda M; Tokita H; Mizuguchi H; Hayakawa T; Todo S; Nakagawara A
Cancer Res; 2002 Apr; 62(8):2203-9. PubMed ID: 11956069
[TBL] [Abstract][Full Text] [Related]
35. Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cells.
Yaswen P; Stampfer MR
Int J Biochem Cell Biol; 2002 Nov; 34(11):1382-94. PubMed ID: 12200033
[TBL] [Abstract][Full Text] [Related]
36. Carcinogen-specific mutational and epigenetic alterations in INK4A, INK4B and p53 tumour-suppressor genes drive induced senescence bypass in normal diploid mammalian cells.
Yasaei H; Gilham E; Pickles JC; Roberts TP; O'Donovan M; Newbold RF
Oncogene; 2013 Jan; 32(2):171-9. PubMed ID: 22410783
[TBL] [Abstract][Full Text] [Related]
37. Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells.
Pratheeshkumar P; Raphael TJ; Kuttan G
Integr Cancer Ther; 2012 Mar; 11(1):48-60. PubMed ID: 21665879
[TBL] [Abstract][Full Text] [Related]
38. Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary gland epithelial cells.
Mandriota SJ; Buser R; Lesne L; Stouder C; Favaudon V; Maechler P; Béna F; Clément V; Rüegg C; Montesano R; Sappino AP
J Biol Chem; 2010 Apr; 285(17):13092-106. PubMed ID: 20177072
[TBL] [Abstract][Full Text] [Related]
39. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence.
Haferkamp S; Tran SL; Becker TM; Scurr LL; Kefford RF; Rizos H
Aging (Albany NY); 2009 May; 1(6):542-56. PubMed ID: 20157537
[TBL] [Abstract][Full Text] [Related]
40. Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells.
Chai J; Charboneau AL; Betz BL; Weissman BE
Cancer Res; 2005 Nov; 65(22):10192-8. PubMed ID: 16288006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
